Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11514647rdf:typepubmed:Citationlld:pubmed
pubmed-article:11514647lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11514647lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:11514647lifeskim:mentionsumls-concept:C0270549lld:lifeskim
pubmed-article:11514647lifeskim:mentionsumls-concept:C0815278lld:lifeskim
pubmed-article:11514647pubmed:issue3lld:pubmed
pubmed-article:11514647pubmed:dateCreated2001-8-21lld:pubmed
pubmed-article:11514647pubmed:abstractTextSerum levels of allopregnanolone, pregnenolone sulfate, and dehydroepiandrosterone sulfate were measured in 8 male patients with generalized anxiety disorder (GAD) and 8 healthy control subjects. Results suggest that patients with GAD have significantly lower levels of pregnenolone sulfate than control subjects.lld:pubmed
pubmed-article:11514647pubmed:languageenglld:pubmed
pubmed-article:11514647pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11514647pubmed:citationSubsetIMlld:pubmed
pubmed-article:11514647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11514647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11514647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11514647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11514647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11514647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11514647pubmed:statusMEDLINElld:pubmed
pubmed-article:11514647pubmed:issn0895-0172lld:pubmed
pubmed-article:11514647pubmed:authorpubmed-author:JhangriG SGSlld:pubmed
pubmed-article:11514647pubmed:authorpubmed-author:Le MellédoJ...lld:pubmed
pubmed-article:11514647pubmed:authorpubmed-author:SemeniukTTlld:pubmed
pubmed-article:11514647pubmed:issnTypePrintlld:pubmed
pubmed-article:11514647pubmed:volume13lld:pubmed
pubmed-article:11514647pubmed:ownerNLMlld:pubmed
pubmed-article:11514647pubmed:authorsCompleteYlld:pubmed
pubmed-article:11514647pubmed:pagination396-8lld:pubmed
pubmed-article:11514647pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:meshHeadingpubmed-meshheading:11514647...lld:pubmed
pubmed-article:11514647pubmed:year2001lld:pubmed
pubmed-article:11514647pubmed:articleTitleNeuroactive steroid levels in patients with generalized anxiety disorder.lld:pubmed
pubmed-article:11514647pubmed:affiliationDepartment of Psychiatry, University of Alberta Hospital, Edmonton, Alberta, Canada. tsemeniu@ualberta.calld:pubmed
pubmed-article:11514647pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11514647pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed